Biomedical Applications of Introductory Physics

por Tuszynski, J A, Dixon, J M
Publicado 2002

Reply: Optimum duration of breast cancer follow-up: a continuing controversy

por Montgomery, D A, Dixon, J M
Publicado 2007

Anastrozole (‘Arimidex’) blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer

por Miller, W R, Stuart, M, Sahmoud, T, Dixon, J M
Publicado 2002

Oestrogen receptor β and neoadjuvant therapy with tamoxifen: prediction of response and effects of treatment

por Miller, W R, Anderson, T J, Dixon, J M, Saunders, P T K
Publicado 2006

Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer

por Anderson, T J, Dixon, J M, Stuart, M, Sahmoud, T, Miller, W R
Publicado 2002

Concentrations of tamoxifen and its major metabolites in hormone responsive and resistant breast tumours

por MacCallum, J, Cummings, J, Dixon, J M, Miller, W R
Publicado 2000

Reproducibility of microvessel counts in breast cancer specimens

por Marson, L P, Kurian, K M, Miller, W R, Dixon, J M
Publicado 1999

Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole

por Miller, W R, White, S, Dixon, J M, Murray, J, Renshaw, L, Anderson, T J
Publicado 2006

Cyclic AMP binding proteins and prognosis in breast cancer.

por Miller, W. R., Elton, R. A., Dixon, J. M., Chetty, U., Watson, D. M.
Publicado 1990

Expression of transforming growth factor beta mRNA isoforms in human breast cancer.

por MacCallum, J., Bartlett, J. M., Thompson, A. M., Keen, J. C., Dixon, J. M., Miller, W. R.
Publicado 1994

Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy.

por MacCallum, J., Keen, J. C., Bartlett, J. M., Thompson, A. M., Dixon, J. M., Miller, W. R.
Publicado 1996

Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience

por Montgomery, D A, Krupa, K, Jack, W J L, Kerr, G R, Kunkler, I H, Thomas, J, Dixon, J M
Publicado 2007

Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors

por Flågeng, M Hauglid, Haugan Moi, L L, Dixon, J M, Geisler, J, Lien, E A, Miller, W R, Lønning, P E, Mellgren, G
Publicado 2009

Prospective evaluation of prognostic factors in operable breast cancer.

por Hawkins, R. A., Tesdale, A. L., Killen, M. E., Jack, W. J., Chetty, U., Dixon, J. M., Hulme, M. J., Prescott, R. J., McIntyre, M. A., Miller, W. R.
Publicado 1996

Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index

por Hawkins, R A, Tesdale, A L, Prescott, R J, Forster, T, McIntyre, M A, Baker, P, Jack, W J L, Chetty, U, Dixon, J M, Killen, M E, Hulme, M J, Miller, W R
Publicado 2002